Skip to main content
SCANCELL HOLDINGS PLC logo

SCANCELL HOLDINGS PLC — Investor Relations & Filings

Ticker · SCLP ISIN · GB00B63D3314 LEI · 2138008RXEG856SNP666 IL Professional, scientific and technical activities
Open in API
Filings indexed 436 across all filing types
Latest filing 2022-04-11 Report Publication Anno…
Country GB United Kingdom
Listing IL SCLP

About SCANCELL HOLDINGS PLC

https://www.scancell.co.uk/

Scancell Holdings PLC is a clinical-stage company developing novel active immunotherapies for the treatment of cancer. Its approach focuses on enhancing long-lasting, tumor-specific immunity to address significant unmet needs in oncology, particularly for hard-to-treat cancers. The company leverages its proprietary technology platforms, Immunobody®, Moditope®, and AvidiMab™, to create targeted, off-the-shelf therapies. The Immunobody® platform generates DNA-based immunotherapies, with its lead candidate, iSCIB1+, targeting advanced melanoma. The Moditope® platform develops peptide-based therapies, with a lead product showing encouraging Phase 2 data in a broad range of solid tumors. Scancell aims to deliver treatments that are safe, effective, easily administered, and accessible to patients.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Report Publication Announcement Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement related to trading procedures, not a comprehensive financial report (like 10-K or IR) or a management/shareholder communication. Given its nature as a general regulatory market notice that doesn't fit the highly specific categories like DIV, DIRS, or ER, the most appropriate classification is the general regulatory announcement fallback category, RNS.
2022-04-11 English
Second Price Monitoring Extn
Capital/Financing Update Classification · 99% confidence The document is very short (1936 characters) and contains the header 'RNS Number : 9654H' and mentions 'RNS, the news service of the London Stock Exchange'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. This type of short, time-sensitive regulatory update that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory announcement category, RNS. It is not a report itself, nor is it a dividend notice, management change, or director dealing.
2022-04-11 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly mentions 'RNS Number', 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider', and contains a standard RNS footer. The content itself is a 'Price Monitoring Extension' announcement regarding an auction call period extension for a security. This type of short, specific regulatory announcement that is distributed via the RNS service fits best under the general 'Regulatory Filings' category, as there is no more specific category for price monitoring extensions or general LSE operational updates. Given the document's nature as a direct regulatory news service update, RNS is the most appropriate code.
2022-04-11 English
Modi-1 Phase 1/2 trial open for recruitment
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated '11 April 2022'. It announces a specific operational update: the opening of recruitment for the Modi-1 Phase 1/2 clinical trial. It mentions regulatory approval from the MHRA and provides forward-looking statements about data availability. The presence of the RNS header, the nature of the announcement (a specific, time-sensitive operational/clinical update), and the concluding boilerplate text referencing RNS, the London Stock Exchange, and MAR regulations strongly indicate this is a regulatory news service announcement. Since it is not a full financial report (10-K, IR), a dividend notice (DIV), or a management change (MANG), the most appropriate classification is the general regulatory announcement category, RNS.
2022-04-11 English
Update on COVIDITY clinical trial
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated March 29, 2022. It announces an update regarding a clinical trial amendment approval by SAHPRA for Scancell Holdings Plc. The content is a formal announcement about a regulatory/operational development (clinical trial expansion) and includes contact details for brokers and advisors, typical of a regulatory news service release. The presence of 'RNS Number' and the closing statement referencing 'RNS, the news service of the London Stock Exchange' strongly indicates this is a general regulatory announcement that doesn't fit the more specific categories like ER, 10-K, or CT. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-03-29 English
Scancell progresses its new anti-glycan mAb
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 0615F' and is dated March 17, 2022. It contains an update on the company's GlyMab™ platform, including scientific progress and a new research agreement. The text concludes with standard disclaimers referencing RNS, the London Stock Exchange, and the Financial Conduct Authority (FCA), and ends with 'END'. This structure is characteristic of a regulatory news service announcement. Since the content is a specific operational/scientific update rather than a formal financial report (like 10-K or IR) or a general announcement of a report's publication (RPA), it fits best under the general 'Regulatory Filings' category, which serves as a fallback for specific regulatory news releases that aren't covered by other codes. It is not a Call Transcript (CT), Earnings Release (ER), or a formal financial statement.
2022-03-17 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.